Body composition in lupus nephritis patients
Keywords:Bioelectrical impedance analysis, Body fat, Lupus nephritis, Sri Lanka, Subcutaneous fat, Visceral fat
Background: The assessment of body fat distribution is an important evaluation in patients with lupus nephritis (LN), which does not practice routinely. The objectives of this study were to determine the body composition by using bioelectrical impedance analysis and to identify the effects of age, body mass index, disease activity, and corticosteroid therapy on body composition.
Methods: This was a single-centered, cross-sectional, and observational study conducted at the nephrology unit, National Hospital Kandy, Sri Lanka. Seventy-nine patients with biopsy-proven LN have participated in the study.
Results: There were 79 lupus nephritis patients enrolled in this study. The duration of LN ranged from 8 months to 32 years. The main non-renal clinical manifestations included skin lesions (59%), arthritis (54%), and oral ulcers (48%). The disease activity was low with a mean SLEDAI score of 1.01 (SD=2.3). The body fat (BF) percentage (p=0.002) and subcutaneous fat (SF) percentage (p<0.001) were significantly low in males compared to females. And, BF percentage was significantly low among patients with SLEDAI-2K 6 (p=0.03). Moreover, there were positive correlations found between SLE disease activity with the BMI (p=0.004), body fat percentage (p=0.001), and visceral fat percentage (p=0.001).
Conclusions: Females are more prone to have a high mean value of body composition parameters than males in this study. There is a negative influence of the body composition parameters reported against the disease activity among LN patients in Sri Lanka.
Ali A, Sayyed Z, Ameer MA, Arif AW, Kiran FN, Iftikhar A, et al. Systemic lupus erythematosus: An overview of the disease pathology and its management. Cureus. 2018;10(9).
Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29(9):1011-20.
Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319-23.
Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825-35.
Iorember FM. Malnutrition in chronic kidney disease. Front Pediatr. 2018;6:161.
Vandewoude MF, Alish CJ, Sauer AC, Hegazi RA. Malnutrition-sarcopenia syndrome: is this the future of nutrition screening and assessment for older adults? J Aging Res. 2012;2012.
Amare H, Hamza L, Asefa H. Malnutrition and associated factors among heart failure patients on follow up at Jimma university specialized hospital, Ethiopia. BMC Cardiovasc Disord. 2015;15(1):128.
Bourke CD, Berkley JA, Prendergast AJ. Immune dysfunction as a cause and consequence of malnutrition. Trends Immunol. 2016;37(6):386-98.
Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol. 1992;19(10):1505-10.
Kipen Y, Strauss BJ, Morand EF. Body composition in systemic lupus erythematosus. Br J Rheumatol. 1998;37(5):514-9.
Martirosov EG, Nikolaev DV, Rudnev SG. Technologies and methods of human body composition assessment. Nauka Publication: Moscow; 2006.
Mridha S. A comparative study on body composition of male and female national level sub-junior volleyball players. Br J Sports Med. 2010;44(Suppl 1):i37-8.
Goossens GH, Jocken JW, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47-66.
Shamekhi Z, Habibagahi Z, Ekramzadeh M, Ghadiri A, Namjoyan F, Malehi AS, et al. Body composition and basal metabolic rate in systemic lupus erythematosus patients. Egypt Rheumatol. 2017;39(2):99-102.
Baxter JD, Forsham PH. Tissue effects of glucocorticoids. Am J Med. 1972;53(5):573-89.